(06/05/12) - Paying too much attention to a patient's age may have deadly consequences when it comes to cancer treatment.
At 91-years-old, nothing slows Bill Owen down.
"I go out and work my garden, go out here and cut me some wood and stack it out here," Owen said.
He's an avid hunter, a WWII vet, a die-hard baseball fan, and now he has another title: cancer survivor.
Doctors diagnosed Bill with stage four lymphoma four years ago. Because of his age, he and his wife were told, "Go home and enjoy what time he had left," Barbara Owen said.
Doctor Heidi Klepin, of Wake Forest Baptist Medical Center, says treatment decisions are difficult because most clinical trials only include younger patients. "It's not clear exactly which older patients are going to benefit from any given therapy."
Treatment recommendations are often based on age alone, but take a fit 80-year-old versus a frail one.
"If you applied the same treatment to both of those patients, you would either under treat the fit 80-year-old patient or over treat and potentially harm the frail 80-year-old patient," Klepin said.
That's where a first of its kind assessment tool comes in. Dr. Klepin used it to evaluate seniors with leukemia. She measured everything from physical function to a patient's mental state. Her findings show those who scored poorly before chemo have a higher risk of death.
"People want to know 'what are the risks for me to go through this therapy? What are the benefits with this type of assessment?' We can start answering those questions," Klepin said.
For Bill, it meant finding another doctor and undergoing chemo.
"I still go all day long," Bill said.
ABC12 Main Station